Publications by authors named "Jan Poolman"

Claim this Profile
E
Epidemiology of Invasive Escherichia coli Disease in Adults Using Routine Healthcare Records from the United States, 2002-2022.
Mark A Schmidt, Maxim Blum, Chukwuemeka Onwuchekwa, Weiming Hu, Jan Poolman

Infect Dis Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of staphylococcus aureus infections after surgical interventions: a systematic review and meta-analysis.
Baher Elezbawy, Nada Abaza, Mirna Fasseeh, Rawda Elshahawy, Yosra S Mahmoud, Jan Poolman

Expert Rev Anti Infect Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective global study of the prevalence of O-serotypes of invasive disease in patients admitted to tertiary care hospitals.
Jeroen Geurtsen, Joachim Doua, Luis Martinez-Martinez, Patricia Ibarra de Palacios, Jeff Powis, Jan Poolman

Epidemiol Infect· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A SpA+LukAB vaccine targeting Staphylococcus aureus evasion factors restricts infection in two minipig infection models.
Jan T Poolman, Victor J Torres, Dominique Missiakas, Suzanne P M Welten, Jeffrey Fernandez

NPJ Vaccines· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic and Disease Burden Associated with Invasive Escherichia coli Disease in the United States.
Mark A Schmidt, Maxim Blum, Judy L Donald, Richard T Meenan, Elvira Carrió, Jan Poolman

Infect Dis Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, reactogenicity, and immunogenicity of different doses of 10-valent Extraintestinal Pathogenic Escherichia Coli (ExPEC10V) bioconjugate vaccine (VAC52416) in healthy Japanese adults aged 60-85 years in a randomized, double-blind, phase 1 study.
Miwa Haranaka, Atsushi Momose, Yoshikazu Nakayama, Yuki Saito, Bart Spiessens, Jan Poolman

J Infect Chemother· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of invasive disease in adults in England, 2013-2017.
Maxim Blum, Jeroen Geurtsen, Eva Herweijer, Michal Sarnecki, Bart Spiessens, Jan Poolman

Epidemiol Infect· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A microbiological and genomic perspective of globally collected Escherichia coli from adults hospitalized with invasive E. coli disease.
Enya Arconada Nuin, Tuba Vilken, Basil Britto Xavier, Joachim Doua, Brian Morrow, Jan Poolman

J Antimicrob Chemother· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unbiased identification of risk factors for invasive Escherichia coli disease using machine learning.
Erik Clarke, Christel Chehoud, Najat Khan, Bart Spiessens, Jan Poolman

BMC Infect Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational study.
Joachim Doua, Jesús Rodríguez-Baño, Rachel Froget, Padma Puranam, Oscar Go, Jan Poolman

Infection· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase 1/2a trial of ExPEC10V vaccine in adults with a history of UTI.
Carlos A Fierro, Michal Sarnecki, Bart Spiessens, Oscar Go, Tracey A Day, Jan Poolman

NPJ Vaccines· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational study.
Joachim Doua, Miquel Ekkelenkamp, Theo Verheij, Oscar Go, Stephen Ruhmel, Jan Poolman

Eur J Clin Microbiol Infect Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Bioconjugate Vaccine (VAC52416) in Adults Aged 60-85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study.
Carlos A Fierro, Michal Sarnecki, Joachim Doua, Bart Spiessens, Oscar Go, Jan Poolman

Open Forum Infect Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colonization with ST131-30R (30R) Corresponds with Increased Serum Anti-O25 IgG Levels and Decreased TNFα and IL-10 Responsiveness to 30R.
Brian D Johnston, Connie Clabots, Tricia Bender, Stephen B Porter, Germie van den Dobbelsteen, Jan Poolman

Pathogens· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Distribution of O Serotypes and Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli Collected From the Blood of Patients With Bacteremia Across Multiple Surveillance Studies.
Eveline Weerdenburg, Todd Davies, Brian Morrow, Aldert L Zomer, Peter Hermans, Jan Poolman

Clin Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Disease in Patients Admitted in Tertiary Care Hospitals.
Joachim Doua, Jeroen Geurtsen, Jesus Rodriguez-Baño, Oliver A Cornely, Oscar Go, Jan Poolman

Open Forum Infect Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomics and pathotypes of the many faces of Escherichia coli.
Jeroen Geurtsen, Mark de Been, Eveline Weerdenburg, Aldert Zomer, Alan McNally, Jan Poolman

FEMS Microbiol Rev· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of extraintestinal pathogenic Escherichia coli O-serotypes and antibiotic resistance in blood isolates collected from patients in a surveillance study in Japan.
Tetsuya Matsumoto, Hiroshige Mikamo, Hiroki Ohge, Katsunori Yanagihara, Eveline Weerdenburg, Jan Poolman

J Infect Chemother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination With Detoxified Leukocidin AB Reduces Bacterial Load in a Staphylococcus aureus Minipig Deep Surgical Wound Infection Model.
Jeffrey Fernandez, Holly Sanders, Jessica Henn, Jolaine M Wilson, Danielle Malone, Jan T Poolman

J Infect Dis· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines.
Chakkumkal Anish, Michel Beurret, Jan Poolman

NPJ Vaccines· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Baird and Douglas.
Marc Bonten, Thomas Verstraeten, Stefan Gravenstein, Jan Poolman

Clin Infect Dis· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and O-Serotypes of Extraintestinal Pathogenic Disease in Patients Undergoing Transrectal Ultrasound Prostate Biopsy: A Prospective Multicenter Study.
Steven Rosenberg, Marc Bonten, Wouter Haazen, Bart Spiessens, Darren Abbanat, Jan Poolman

J Urol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
Steven Rosenberg, Marc Bonten, Wouter Haazen, Bart Spiessens, Darren Abbanat, Jan Poolman

J Urol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Bacterial vaccines].
Jan T Poolman

Ned Tijdschr Geneeskd· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections.
Jan T Poolman

NPJ Vaccines· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis